|
Medicis Pharmaceutical Corp and Ipsen announced that the U.S. Food & Drug Administration approved their injectable drug Dysport for cervical dystonia as well as an anti-wrinkle treatment. Ipsen is expected to launch Dysport for cervical dystonia during the second half of 2009. The drug, which will compete with Allergan's Botox, will be marketed under the name Dysport for both therapeutic and aesthetic use. |
|
|
|
|
|
Donate
Make the freedom to move a reality to everyone.
|
|
sitemap / privacy policy / contact us